Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 6Recruiting 5Active not recruiting 4Not yet recruiting 3Unknown 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Breast Neoplasms 10Neoplasms 5Colorectal Neoplasms 4Neoplasm Metastasis 3Prostatic Neoplasms 2Lung Neoplasms 2Vomiting 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Skin Carcinoma 1Postoperative Complications 1Polycystic Ovary Syndrome 1Peripheral Arterial Disease 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Pain 1Opioid-Related Disorders 1Nausea 1Multiple Myeloma 1Mouth Neoplasms 1Motor Activity 1Melanoma 1Medication Adherence 1Malignant Solid Neoplasm 1Lymphoma, Follicular 1Localised Prostate Cancer 1Laryngeal Neoplasms 1Ischemia 1Hypertension 1Hemianopsia 1

Interventions

Cyclophosphamide 4trastuzumab deruxtecan 3fludarabine 3Standard of Care 3Injections 3Cisplatin 3Bevacizumab 3toripalimab 2sacituzumab govitecan 2pembrolizumab 2fludarabine phosphate 2Specimen Handling 2Radiosurgery 2Pemetrexed 2Palliative Care 2Gemcitabine 2Fulvestrant 2Fluorouracil 2Docetaxel 2130-nm albumin-bound paclitaxel 2zimberelimab 1vedolizumab 1tislelizumab 1sintilimab 1ribociclib 1lobaplatin 1lenvatinib 1ivosidenib 1irinotecan sucrosofate 1exemestane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasm Metastasis × Standard of Care × Clear all
NCT07540650 2026-04-20

pRevenT

Institute of Oncology Ljubljana

Phase 2 Not yet recruiting
90 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT07346209 2026-04-08

STRIPe

University of California, San Diego

Phase 2 Not yet recruiting
280 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06961188 2025-05-07

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
174 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡